BROOKLYN IMMUNOTHERAPEUTICSCS INC
BROOKLYN IMMUNOTHERAPEUTICSCS INC
Share · US1140821000 · BTX (XASE)
Overview
No Price
31.01.2026 00:00
Current Prices from BROOKLYN IMMUNOTHERAPEUTICSCS INC
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
BTX
USD
31.01.2026 00:00
6,72 USD
0,04 USD
+0,60 %
XNYS: NYSE
NYSE
BTX
USD
30.01.2026 21:00
6,68 USD
-0,15 USD
-2,20 %
Share Float & Liquidity
Free Float 1,44 %
Shares Float 1,68 M
Shares Outstanding 116,71 M
Company Profile for BROOKLYN IMMUNOTHERAPEUTICSCS INC Share
BlackRock Innovation and Growth Trust (the Trust) is a newly-organized, non-diversified, closed-end management investment company with no operating history. The Trusts investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. There can be no assurance that the Trusts investment objectives will be achieved or that the Trusts investment program will be successful The Trust will invest primarily in equity securities issued by mid- and small-capitalization companies that the Trusts adviser believes have above-average earnings growth potential. In selecting investments for the Trust, the Trusts adviser focuses on mid- and small-capitalization growth companies that are innovative. These are companies that have introduced, or are seeking to introduce, a new product or service that potentially changes the marketplace.
AI Analysis of BROOKLYN IMMUNOTHERAPEUTICSCS INC
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of BROOKLYN IMMUNOTHERAPEUTICSCS INC
No AI threads available for this company yet.

Company Data

Name BROOKLYN IMMUNOTHERAPEUTICSCS INC
Company BlackRock Technology and Private Equity Term Trust
Symbol BTX
Website https://www.brooklynitx.com
Primary Exchange XASE AMEX
ISIN US1140821000
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO John M. Perlowski
Market Capitalization 774 Mio
Country United States of America
Currency USD
Employees -
Address 10355 Science Center Drive, 92121 San Diego
IPO Date 1991-08-29
Dividends from 'BROOKLYN IMMUNOTHERAPEUTICSCS INC'
Ex-Date Dividend per Share
20.01.2026 0,05 USD
20.01.2026 0,05 USD
22.12.2025 0,05 USD
22.12.2025 0,05 USD
14.11.2025 0,05 USD
14.11.2025 0,05 USD
15.10.2025 0,05 USD
15.10.2025 0,05 USD
15.09.2025 0,08 USD
15.09.2025 0,08 USD

Stock Splits

Date Split
17.10.2022 1:20
26.03.2021 1:2
17.06.2016 1:50

ID Changes

Date From To
20.02.2025 BIGZ BTX

Ticker Symbols

Name Symbol
NASDAQ BTX
More Shares
Investors who hold BROOKLYN IMMUNOTHERAPEUTICSCS INC also have the following shares in their portfolio:
ALIGN TECHNOLOGIESLOGY INC
ALIGN TECHNOLOGIESLOGY INC Share
AMGEN INC
AMGEN INC Share
APPLE INC
APPLE INC Share
AUTODESK INC
AUTODESK INC Share
AXA WLD-FR.EU.SM.C.A T
AXA WLD-FR.EU.SM.C.A T Fund
BERKSHIRE HATHAWAY INC - CLASS B
BERKSHIRE HATHAWAY INC - CLASS B Share
CADENCE DESIGN SYSTEMS INC
CADENCE DESIGN SYSTEMS INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
INTEL CORP
INTEL CORP Share
KONINKLIJKE DSM 16/26 MTN
KONINKLIJKE DSM 16/26 MTN Bond
MICROSOFT CORP
MICROSOFT CORP Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
WELLS FARGO & COMPANY ZERO CPN CALL NTS 12/03/49
WELLS FARGO & COMPANY ZERO CPN CALL NTS 12/03/49 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026